GigCapital2, Inc. (GIX) Shareholders Approve UpHealth, Cloudbreak Deal
by Marlena Haddad on 2021-06-04 at 5:05pm

GigCapital2, Inc. (NYSE:GIX) announced that its shareholders approved its combination with UpHealth and Cloudbreak with at a special meeting earlier today.

The SPAC did disclose redemption figures but noted that 65.7% of shares participated in the vote, which is cutting mighty close to the standard 65% minimum turnout threshold. GigCapital2 announced this morning it had dodged at least one potential chunk of redemptions by agreeing to purchase up to 1,700,000 shares held by Kepos Alpha Master Fund at a later date granted that this investor did not redeem them at the vote.

According to the agreement, GigCapital2 will buy these shares for $10.30225 each on September 8, but also allows for Kepos to sell these shares earlier on the open market as long as they do so for a price of $10.10 or higher. The terms further agreed to price increases should the deal not be completed by September 8, but something truly strange would have to happen for that to be the case now that GigCapital2 has gotten through this vote.

GigCapital2 hit a low of $9.40 and closed still below trust value at $9.92 on the day of its June 2 redemption deadline so it likely felt it needed some extra backstop insurance that it would meet the deal’s minimum cash condition of $150 million.

The parties initially announced their $1.35 billion deal on November 23.  UpHealth Holdings is one of the largest national and international digital healthcare providers that has an integrated solutions platform and Cloudbreak is a leading unified telemedicine and video medical interpretation solutions provider.


ADVISORS

  • Needham & Company serves as exclusive financial advisor to UpHealth.
  • Husch Blackwell LLP serves as legal counsel to UpHealth and Plante Moran, PLLC serves as auditors to UpHealth.
  • Sidley Austin LLP serves as legal counsel to Cloudbreak.
  • Nomura Securities International, Inc. serves as Exclusive Financial and Capital Markets Advisor to GigCapital2
  • DLA Piper LLP (US) serves as legal counsel, and BPM LLP serves as auditors to GigCapital2.
Recent Posts
by Nicholas Alan Clayton on 2024-05-01 at 7:41am

At the SPAC of Dawn Of the days with potential to shake up the market with news this week, today is the big one. Markets are currently anticipating a “near-zero” chance of any changes in the Fed’s rate-cut schedule coming out of today’s meeting. But, other news could come in a change in policy on...

by Nicholas Alan Clayton on 2024-04-30 at 4:25pm

The pace of de-SPACs making it to their lock-up expirations is set to roughly remain level with last month as May’s batch includes five companies and six sponsors set to be released. This group features a high number of Asia-based deals including its headline performer, SunCar Technology (NASDAQ:SDA), which last closed at $7.91. Earlier this...

by Nicholas Alan Clayton on 2024-04-30 at 2:01pm

DT Cloud Star (NASDAQ:DTSQU) filed an S-1 to raise $60 million as the second SPAC by its sponsor team, but this venture would be the 13th foray by underwriter Alliance Global Partners and the first under its new branding as AGP. However, three of those initial filings have subsequently been withdrawn. Nonetheless, AGP is offering...

by Nicholas Alan Clayton on 2024-04-30 at 8:15am

At the SPAC of Dawn Tuesday brings another packed day in a packed week of potentially market-moving events and individual SPAC actions. The market today will take in the update on US consumer confidence readings as well as the employment cost index and Treasury’s decision on its quarterly refunding plans. An unusually large portion of...

by Nicholas Alan Clayton on 2024-04-29 at 4:03pm

Few target companies have gone through a greater amount of change through the course of their de-SPACing process than digital transformation firm Noventiq, which makes its latest update via a new investor presentation a particularly interesting read. When it initially announced its combination with Corner Growth (NASDAQ:COOL) in May 2023, Noventiq was still listed in...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved